-
1
-
-
13444294295
-
Vulnerability to mental illnesses: Gender makes a difference
-
Andreasen N. Vulnerability to mental illnesses: gender makes a difference. Am J Psychiatry 2005;162:211-3.
-
(2005)
Am J Psychiatry
, vol.162
, pp. 211-213
-
-
Andreasen, N.1
-
2
-
-
0029990882
-
The origins of sex differences in depressive disorder: Bridging the gap
-
Bebbington PE. The origins of sex differences in depressive disorder: bridging the gap. Int Rev Psychiatry 1996;8:295-33.
-
(1996)
Int Rev Psychiatry
, vol.8
, pp. 295-333
-
-
Bebbington, P.E.1
-
3
-
-
0034983405
-
Quality assurance in psychopharmalogical treatment: The AMSP drug safety program
-
Bender S, Grohmann R. Quality assurance in psychopharmalogical treatment: the AMSP drug safety program. Psycho 2001;27:198-204.
-
(2001)
Psycho
, vol.27
, pp. 198-204
-
-
Bender, S.1
Grohmann, R.2
-
4
-
-
0034945769
-
Is gender a risk factor for adverse drug reactions?
-
Drici M, Clement N. Is gender a risk factor for adverse drug reactions? Drug Saf 2001; 24:575-85.
-
(2001)
Drug Saf
, vol.24
, pp. 575-585
-
-
Drici, M.1
Clement, N.2
-
5
-
-
25844455109
-
Die bessere und die schlechtere Hälfte? Geschlechtsunterschiede in der Prävalenz psychischer Krankheiten
-
Riecher-Rössler A, Rohde A Hrsg, Basel: Karger
-
Ernst C. Die bessere und die schlechtere Hälfte? Geschlechtsunterschiede in der Prävalenz psychischer Krankheiten. In: Riecher-Rössler A, Rohde A (Hrsg.). Psychische Erkrankungen bei Frauen. Basel: Karger, 2001:47-61.
-
(2001)
Psychische Erkrankungen bei Frauen
, pp. 47-61
-
-
Ernst, C.1
-
6
-
-
38949143392
-
-
Haen E. Qualitätssicherung in der Psychopharmakotherapie. Neurotransmitter 2004;7/8: 37-43.
-
Haen E. Qualitätssicherung in der Psychopharmakotherapie. Neurotransmitter 2004;7/8: 37-43.
-
-
-
-
7
-
-
0017356624
-
Sex differences and the epidemiology of depression
-
Weissman MM, Klerman GL. Sex differences and the epidemiology of depression. Arch Gen Psychiatry 1977;3:98-112.
-
(1977)
Arch Gen Psychiatry
, vol.3
, pp. 98-112
-
-
Weissman, M.M.1
Klerman, G.L.2
-
8
-
-
33645699774
-
Gender aspects in the clinical treatment of schizophrenic inpatients with amisulpride: A therapeutic drug monitoring study
-
Müller M, Regenbogen B. Gender aspects in the clinical treatment of schizophrenic inpatients with amisulpride: A therapeutic drug monitoring study. Pharmacopsychiatry 2006;39:41-6.
-
(2006)
Pharmacopsychiatry
, vol.39
, pp. 41-46
-
-
Müller, M.1
Regenbogen, B.2
-
9
-
-
0033655196
-
Sex differences in schizophrenia, a review of the literature
-
Leung A, Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl 2000;401:3-38.
-
(2000)
Acta Psychiatr Scand Suppl
, vol.401
, pp. 3-38
-
-
Leung, A.1
Chue, P.2
-
10
-
-
0035666654
-
-
Rademaker M. Do women have more adverse drug reactions? Am J Clin Dermatology 2001;2:349-51.
-
Rademaker M. Do women have more adverse drug reactions? Am J Clin Dermatology 2001;2:349-51.
-
-
-
-
11
-
-
3342908588
-
Gender differences in the prescribing of antipsychotic drugs
-
Seeman M. Gender differences in the prescribing of antipsychotic drugs. Am J Psychiatry 2004;161:1324-33.
-
(2004)
Am J Psychiatry
, vol.161
, pp. 1324-1333
-
-
Seeman, M.1
|